Ber-EP4 antigen is a marker for a cell population related to the secondary hair germ

Experimental Dermatology

Volumn 13, Issue 7, 2004, Pages 401-405

  Ozawa, Maki ^a   Aiba, Setsuya ^a   Kurosawa, Masahiro ^a   Tagami, Hachiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ber EP4; Keratin 15; Keratin 19; Secondary hair germ

Indexed keywords

ANTIGEN; BER EP4 ANTIGEN; BIOCHEMICAL MARKER; CELL MEMBRANE PROTEIN; KERATIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER EP4; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOCRINE GLAND; ARTICLE; BASAL CELL CARCINOMA; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; FETUS CELL; GERM CELL; HAIR FOLLICLE; HAIR GROWTH; HAIR ROOT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN EXPRESSION; SKIN STRUCTURE; STEM CELL; SWEAT GLAND; TRICHOEPITHELIOMA;

ANTIBODIES, MONOCLONAL; CELL MEMBRANE; GLYCOPROTEINS; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; SKIN;

EID: 4043175507     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00153.x     Document Type: Article

References (26)

1. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 1990: 43: 213-219.
2. Sheibani K, Shin S S, Kezirian J, Weiss L M. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991: 15: 779-784.
3. Gaffey M J, Mills S E, Swanson P E, Zarbo R J, Shah A R, Wick M R. Immunoreactivity for BER-EP4 in adenocarcinomas, adenomatoid tumors, and malignant mesotheliomas. Am J Surg Pathol 1992: 16: 593-599.
4. Tellechea O, Reis J P, Domingues J C, Baptista A P. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 1993: 15: 452-455.
5. Swanson P E, Fitzpatrick M M, Ritter J H, Glusac E J, Wick M R. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol 1998: 25: 153-159.
6. Jones M S, Helm K F, Maloney M E. The immunohistochemical characteristics of the basosquamous cell carcinoma. Dermatol Surg 1997: 23: 181-184.
7. Beer T W, Shepherd P, Theaker J M. Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 2000: 37: 218-223.
8. Jimenez F J, Burchette J L Jr, Grichnik J M, Hitchcock M G. Ber-EP4 immunoreactivity in normal skin and cutaneous neoplasms. Mod Pathol 1995: 8: 854-858.
9. Waseem A. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol 1999: 112: 362-369.
10. Commo S, Gaillard O, Bernard B A. The human hair follicle contains two distinct K19 positive compartments in the outer root sheath: a unifying hypothesis for stem cell reservoir? Differentiation 2000: 66: 157-164.
11. Potten C S, Booth C. Keratinocyte stem cells: a commentary. J Invest Dermatol 2002: 119: 888-899.
12. Lyle S, Christofidou-Solomidou M, Liu Y, Elder D E, Albelda S, Cotsarelis G. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci 1998: 111: 3179-3188.
13. Akiyama M, Lynne T S, Shimizu H. Changing patterns of localization of putative stem cells in developing human hair follicle. J Invest Dermatol 2000: 114: 321-327.
14. Cotsarelis G, Kaur P, Dhouailly D, Hengge U, Bickenbach J. Epithelial stem cells: definition, markers, localization and functions. Exp Dermatol 1999: 8: 80-88.
15. Jones P H, Harper S, Watt F M. Stem cell patterning and fate in human epidermis. Cell 1995: 80: 83-93.
16. Lane E B, Wilson C A, Hughes B R, Leigh I M. Stem cells in hair follicles. Ann N Y Acad Sci 1991: 642: 197-213.
17. Michel M, Torok N, Godbout M J et al. Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 1996: 109: 1017-1028.
18. Muller-Rover S, Handjiski B, van der Veen C et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001: 117: 3-15.
19. Silver A F, Chase H B. The incorporation of tritiated uridine in hair germ and dermal papilla during dormancy (telogen) and activation (early anagen). J Invest Dermatol 1977: 68: 201-205.
20. Stenn K S, Paus R. Controls of hair follicle cycling. Physiol Rev 2001: 81: 449-494.
21. Silver A F, Chase H B, Arsenault C T. Early anagen initiated by plucking compared with early spontaneous anagen. In: Montagna W, Dobson R L, eds. Adv Biol Skin. New York: Pergamon Press, 1969: 265-286.
22. Chase H B. Growth of hair. Physiol Rev 1954: 34: 113-126.
23. Stenn K S, Paus R. What controls hair follicle cycling? Exp Dermatol 1999: 8: 229-233 [discussion 233-236].
24. Cotsarelis G, Sun T T, Lavker R M. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990: 61: 1329-1337.
25. Sun T T, Cotsarelis G, Lavker R M. Hair follicular stem cells: the bulge-activation hypothesis. J Invest Dermatol 1991: 96: 77S-78S.
26. Panteleyev A A, Jahoda C A, Christiano A M. Hair follicle predetermination. J Cell Sci 2001: 114: 3419-3431.